🔎 Trials Near Me

Utama › Melanoma › Ohio › Cincinnati

Kajian klinikal Melanoma di Cincinnati, OH

17 kajian untuk Melanoma sedang mencari peserta di lokasi dalam dan sekitar Cincinnati (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Good Samaritan Hospital - Cincinnati, Cincinnati
  • Oncology Hematology Care Inc-Kenwood, Cincinnati
  • Bethesda North Hospital, Cincinnati
  • dan 3 lagi
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Mengambil pesertaFasa 3
  • Oncology Hematology Care Clinical Trials, Cincinnati
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06246916

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

Mengambil pesertaFasa 3
  • Oncology Hematology Care, Cincinnati
Umur 18 hingga 70 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT05727904

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Mengambil pesertaFasa 3
  • Good Samaritan Hospital - Cincinnati, Cincinnati
  • Bethesda North Hospital, Cincinnati
  • TriHealth Cancer Institute-Westside, Cincinnati
  • dan 1 lagi
Umur 75 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07068074

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Mengambil pesertaFasa 2
  • Oncology Hematology Care Inc-Kenwood, Cincinnati
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT04511013

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • University of Cincinnati Medical Center, Cincinnati
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07287917

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Mengambil pesertaFasa 1/2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
12 Months – 30 Years · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT04851119

Project: Every Child for Younger Patients With Cancer

Mengambil pesertaKajian pemerhatian
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Sehingga umur 25 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT02402244

Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • University of Cincinnati Cancer Center, Cincinnati
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Ogo 2026 · NCT06425926

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

Mengambil pesertaFasa 1/2
  • University of Cincinnati, Cincinnati
Umur 18 hingga 70 · Semua jantina · Dikemas kini 11 Jun 2026 · NCT05361174

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

Mengambil pesertaFasa 1/2
  • University of Cincinnati Cancer Center, Cincinnati
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Jun 2026 · NCT03947385

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Mengambil pesertaFasa 1/2
  • Christ Hospital Cancer Center, Cincinnati
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Mei 2026 · NCT05379985

Promoting Immunotherapy Efficacy With Low-Dose Liver RT

Mengambil peserta
  • University of Cincinnati Medical Center, Cincinnati
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Feb 2026 · NCT07225036

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Mengambil pesertaFasa 3
  • St Elizabeth Healthcare (St Elizabeth Medical Center), Edgewood · 8 mi jauh
  • St Elizabeth Healthcare (St Elizabeth Medical, Edgewood · 8 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Feb 2026 · NCT05549297

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Mengambil pesertaFasa 1/2
  • Research Site 113, Cincinnati
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Nov 2025 · NCT05914116

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, Cincinnati
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Mengambil peserta
  • University of Cincinnati, Cincinnati
  • West Chester Hospital (OH394), West Chester · 15 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Nov 2024 · NCT03860883

Kajian Melanoma di bandar lain

Kajian lain di Cincinnati

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.